Innovation for Health - 15-16 April 2021
Innovation for Health - Shaping the future of healthcare

Peter Roevens

PhD, Principal Scientist, Early Discovery Expert; Campus Office & Alliance Management, Janssen Pharmaceutica NV

Peter is a pharmacologist with 35 years of experience at Janssen. Heading Enabling Technologies, encompassing Compound Logistics, Gene 2 Protein, Assay Development, High Throughput Screening, Hit to Lead & Lead Optimization Profiling, in vivo Pharmacology, Functional Genomics and pre-clinical Pharmacokinetics, he supported the whole spectrum of drug discovery projects in all therapeutic areas Janssen has been active in over the past 20 years. He combined this role with leadership of Drug Discovery Projects in Metabolic Diseases from lab to clinic. He played a major role in the initiation of the European Lead Factory (ELF) Project (2012), is championing the participation of Janssen and is also a member of the ELF Target Review Committee.
Jan van de Winkel
Eline Vrijland-van Beest
Hybridize Therapeutics

Carmen van Vilsteren
Topsector Life Science & Health

Tim Van Hauwermeiren 

Antoon van Oosterhout
Imyse SA
Willem Mulder
Jolanda M. de Vries
Yvette van Kooyk
Amsterdam UMC
Ronald Plasterk
Frame Cancer Therapeutics
Paul WG Elbers
Amsterdam UMC
Prof. Dr. Ing. Ron A.M. Fouchier
Erasmus MC
Sponsors & Partners 2021
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Main Virtual Conference sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: